hers.com semaglutide Hims & Hers in talks with Novo Nordisk over Wegovy return | Pharmaceutical Hims & Hers to bring

When comparing the hair loss status of the four study groups after 9-month, to the baseline, it turned out that on average all three groups that received a treatment, had a reduced hair loss rate, but not the no-treatment control

It is hoped that over the long-term, effects of GLP-1 analogs will preserve beta-cell function and increase beta-cell mass, a much-desired effect in type 2 diabetes patients

a triple agonist hitting GLP-1, GIP, and glucagon simultaneously is moving body composition, metabolic rate, bone density, and lean mass on completely different timelines.

Academic Press: Cambridge, UK, 1997 pp 209210